Article Versions Notes

Iftikhar A, Hassan H, Iftikhar N, Mushtaq A, Sohail A, Rosko N, Chakraborty R, Razzaq F, Sandeep S, Valent JN, et al. Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development. Antibodies. 2019; 8(2):34. https://doi.org/10.3390/antib8020034

Iftikhar, Ahmad, Hamza Hassan, Nimra Iftikhar, Adeela Mushtaq, Atif Sohail, Nathaniel Rosko, Rajshekhar Chakraborty, Faryal Razzaq, Sonia Sandeep, Jason Neil Valent, and et al. 2019. "Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development" Antibodies 8, no. 2: 34. https://doi.org/10.3390/antib8020034

Iftikhar, A., Hassan, H., Iftikhar, N., Mushtaq, A., Sohail, A., Rosko, N., Chakraborty, R., Razzaq, F., Sandeep, S., Valent, J. N., Kanate, A. S., & Anwer, F. (2019). Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development. Antibodies, 8(2), 34. https://doi.org/10.3390/antib8020034